Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring

Therapeutic Drug Monitoring

Volumn 22, Issue 4, 2000, Pages 386-391

  Pea, Federico ^a   Milaneschi, Rosanna ^b   Baraldo, Massimo ^a   Lugatti, Emilio ^b   Talmassons, Giovanni ^b   Furlanut, Mario ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Ciprofloxacin; Elderly patients; LRTI; Pharmacokinetics; Sequential therapy

Indexed keywords

CIPROFLOXACIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG MONITORING; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS;

EID: 0033854347     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200008000-00004     Document Type: Article

References (32)

1. In vitro activity of ciprofloxacin, a new carboxy-quinoline antimicrobial agent
2. In vitro activity of ciprofloxacin against aerobic bacteria isolated in a Southern European Hospital
3. In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates
4. Multicenter in vitro comparative study of fluoroquinolones against 25,129 Gram-positive and Gram-negative clinical isolates
5. In vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: A Canadian multicenter study
6. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: A 10 years perspective
7. Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly
8. Lower respiratory tract infection therapy - The role of ciprofloxacin
9. Evalutation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections
10. The selection of appropriate dosages for intravenous ciprofloxacin
11. Pharmacokinetics of ciprofloxacin in the elderly: Increased oral bioavailability and reduced renal clearance
12. Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients
13. Influence of age on the pharmacokinetics of ciprofloxacin
14. The value of routine microbial investigation in community-acquired pneumonia
15. Prediction of creatinine clearance from serum creatinine
16. Improved high performance liquid chromatograpic determination of ciprofloxacin and its metabolites in human specimens
17. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents
18. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
19. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones
20. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
21. Antibiotic dosing issues in lower respiratory tract infections: Population-derived area under inhibitory curve is predictive of efficacy
22. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections
23. Questioning dosing regimens of ciprofloxacin
24. Oral ciprofloxacin. A pharmacoeconomic evaluation of its use in the treatment of serious infections
25. Pharmacokinetics in the elderly. Studies on ciprofloxacin
26. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients
27. Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration
28. Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers
29. Accumulation of new quinolones in the blood of elderly patients
30. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects
31. Serum ciprofloxacin concentrations in patients with severe sepsis being treated with ciprofloxacin 200 mg iv bd irrespective of renal function
32. Principles of antibiotic prescribing in the elderly